IP Verse

Schlich patent opposition analysis

The comprehensive analysis of Schlich opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Schlich

Stay updated with the latest patent oppositions filed by Schlich

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4079311
Nmn And Derivatives For Its Use In The Treatment Of Depression And/Or Anxiety In Patients Having A Form Of ParkinsonismNUVAMID SAJul 1, 2026SCHLICH
EP3197375
Multi-Planar Variable Geometry Zigzag Cut Articulating Drilling SystemTHINK SURGICAL, INC.Jun 16, 2026STRAWMAN
EP3553174
Rna-Guided Human Genome EngineeringPRESIDENT AND FELLOWS OF HARVARD COLLEGEJan 30, 2026SCHLICH
EP3709026
Instrument For Analyzing Biological Samples And ReagentsLGC GENOMICS, LLCApr 17, 2025CR BIOSCIENCE
EP3501610
Housing Of A Closed Circuit Breathing ApparatusDRÄGER SAFETY AG & CO. KGAAOct 31, 2024SCHLICH
EP4028021
Use Of Nmn For The Prevention And/Or Treatment Of Pain, And Corresponding CompositionsNUVAMID SAMay 30, 2024SCHLICH
EP4084799
Use Of Nmn For The Prevention And/Or Treatment Of Joint Pain Induced By Physical Activity, And Corresponding CompositionsNUVAMID SAMay 30, 2024SCHLICH
EP4196127
Nicotinamide Mononucleotide Derivatives And Use Thereof In The Treatment And Prevention Of A Red Blood Cell DisorderNUVAMID SAMay 30, 2024SCHLICH
EP3578175
Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENAug 30, 2023GLENMARK PHARMACEUTICALS EUROPE
EP2653873
Compositions And Uses For Treating Multiple SclerosisBIOGEN MA INC.Apr 19, 2023GLENMARK PHARMACEUTICALS EUROPE

Top clients of Schlich

Top companies who are the clients of Schlich

CompanyTotal
SCHLICH29
GLENMARK PHARMACEUTICALS EUROPE15
CR BIOSCIENCE1
IMUTEX LIMITED1
JÓSAFATSSON, ATLI MÁR1
STRAWMAN1